2[1]Tokuchi Y,Hashimoto T,Kobayashi Y,et al.The expression of p73 is increased in lung cancer,independent of p53 gene alteration.Br J Cancer.1999,80:1623-29.
3[2]Kovalev S,Marchenko N,Swendeman S,et al Expression level,allelic origin,and mutation analysis of the p73 gene in neuroblaseoma tumors and cell lines.Cell Growth Differ 1998,9:897-903.
4[3]Guran S,Bahce M,Beyan C,et al P53,pl5INK4B,pl6INK4Aand p57KIP2 mutations during the progression of chronic myeloid leukemia.Haematologia 1998,29:181-93.
5[4]Ito Y,Takeda T,Wakasa K,et al Expression of p57/kip2 protein in pancreatic adenocarcinoma.Pancreas.2001,23:246-50.
6[5]Petrition EF,Ardekani AM,Hitt BA,et al.Use of proteomic patterns in serum to identify ovarian cancer.Lancet,2002,359:572-77.
7[6]Vlahou A,Schellhammer PF,Mendrinon S,et al.Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.Am J Pathol 2001,158:1491-1502.
8[7]Aharm M,Best C J,Flaig M J,et al.Proteomic analysis of human prostate.Cancer Mol Carcinog,2002,33:9-15.
9[9]Ohyashiki K,Iwama H,Tauchi T,et al.Telomere dynamics and genetic instability in disease progression of chronic myeloid leukemia.Leuk Lymphoma.2000,40:49-56.
10[11]Chambers G,Lawrie L,Cash P et al Proteomics:a new approach to the study of disease.J Pathol,2000,192:280-88.
